Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NQO1 | P15559 | 1/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | PDE10A | Q9Y233 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | PDE5A | O76074 | 3/20 | 0.39 |
| ▸ | PDE4A | P27815 | 3/20 | 0.39 |
| ▸ | PDE1A | P54750 | 3/20 | 0.39 |
| ▸ | PDE1B | Q01064 | 3/20 | 0.39 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.39 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.39 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.39 |
| ▸ | PDE3B | Q13370 | 3/20 | 0.39 |
| ▸ | PDE1C | Q14123 | 3/20 | 0.39 |
| ▸ | PDE3A | Q14432 | 3/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4639701 | 0.87 | NQO1 (0.50) | NQO1PTGS2MAPTNPC1SMN1; SMN2 | |
| SCHEMBL11893005 | 0.87 | PTGES (0.46) | NQO1PTGS2MAPTNPC1SMN1; SMN2 | |
| SCHEMBL16267147 | 0.78 | CYP2A6 (0.46) | NQO1MAPTNPC1KDM4EALDH1A1 | |
| SCHEMBL28859156 | 0.77 | NQO1 (0.42) | NQO1MAPTSMN1; SMN2PDE10AKDM4E | |
| SCHEMBL7889092 | 0.77 | NQO1 (0.53) | NQO1MAPTNPC1SMN1; SMN2KDM4E | |
| SCHEMBL11450871 | 0.75 | KDM4E (0.47) | PTGS2MAPTSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL2876970 | 0.73 | NQO1 (0.44) | NQO1MAPTSMN1; SMN2PDE10AKDM4E | |
| SCHEMBL19019819 | 0.73 | TLR8 (0.42) | NQO1MAPTNPC1PDE10AKDM4E | |
| SCHEMBL9483707 | 0.73 | NQO1 (0.47) | NQO1MAPTSMN1; SMN2KDM4EALDH1A1 | |
| SCHEMBL4238902 | 0.71 | NQO1 (0.46) | NQO1MAPTNPC1SMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3453751-A1 | USE OF GLYCERIN SHORT-CHAIN ALIPHATIC ETHER COMPOUNDS | Ecolab USA Inc. (US) | 2019-03-13 | — | — | EP | disclosed |
| US-8901056-B2 | Reducing viscosity utilizing glycerin short-chain aliphatic ether compounds | ECOLAB USA INC. (US) | 2014-12-02 | — | — | US | disclosed |
| US-20120309849-A1 | USE OF GLYCERIN SHORT-CHAIN ALIPHATIC ETHER COMPOUNDS | ECOLAB USA INC. | 2012-12-06 | — | — | US | disclosed |
| US-6548189-B1 | Epoxidized cashew nutshell liquid, a catalyst, and bisphenol a diglycidyl ether | GENERAL ELECTRIC COMPANY | 2003-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120309849-A1 | USE OF GLYCERIN SHORT-CHAIN ALIPHATIC ETHER COMPOUNDS | GK, PHOSPHO1, UGCG | NQO1 4455/4885PTGS2 563/4885MAPT 1694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.